Xueshan Sun

1.5k total citations
41 papers, 969 citations indexed

About

Xueshan Sun is a scholar working on General Health Professions, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Xueshan Sun has authored 41 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in General Health Professions, 8 papers in Molecular Medicine and 8 papers in Applied Microbiology and Biotechnology. Recurrent topics in Xueshan Sun's work include Global Health Care Issues (8 papers), Antibiotic Use and Resistance (8 papers) and Antibiotic Resistance in Bacteria (8 papers). Xueshan Sun is often cited by papers focused on Global Health Care Issues (8 papers), Antibiotic Use and Resistance (8 papers) and Antibiotic Resistance in Bacteria (8 papers). Xueshan Sun collaborates with scholars based in China, Sweden and United States. Xueshan Sun's co-authors include Hengjin Dong, Xuemei Zhen, Xiaoqian Hu, Cecilia Stålsby Lundborg, Shuyan Gu, Yuxuan Gu, Yuanyuan Li, Jingming Wei, Nina Zhu and Meiling Zhang and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and International Journal of Environmental Research and Public Health.

In The Last Decade

Xueshan Sun

38 papers receiving 951 citations

Peers

Xueshan Sun

AMB

GHP

EPIDE

Xuemei Zhen China

Shuyan Gu China

Laurent Molinier France

Min-Jeong Park South Korea

Eleni Ioannidou Greece

Edoardo Pozzi Italy

G. Phillips United Kingdom

Varshil Mehta India

Sayeeda Rahman United Kingdom

Sanjay Merchant United States

Xuemei Zhen China

Xueshan Sun

244 ×1.1

168 ×1.0

185 ×1.2

AMB

121 ×1.0

GHP

130 ×1.1

EPIDE

Citations per year, relative to Xueshan Sun Xueshan Sun (= 1×) peers Xuemei Zhen

Countries citing papers authored by Xueshan Sun

Since Specialization

Citations

This map shows the geographic impact of Xueshan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueshan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueshan Sun more than expected).

Fields of papers citing papers by Xueshan Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueshan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueshan Sun. The network helps show where Xueshan Sun may publish in the future.

Co-authorship network of co-authors of Xueshan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xueshan Sun. A scholar is included among the top collaborators of Xueshan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueshan Sun. Xueshan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhen, Xuemei, Xueshan Sun, Yixi Chen, et al.. (2024). Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model. BMJ Open. 14(8). e086039–e086039. 1 indexed citations

Zhang, Mingming, et al.. (2023). Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China. Journal of Medical Economics. 26(1). 701–709. 8 indexed citations

Hu, Xiaoqian, Shuyan Gu, Xuemei Zhen, et al.. (2022). Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis. European Journal of Ageing. 19(4). 1167–1179. 10 indexed citations

Zhao, Zixuan, et al.. (2021). Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis. Journal of Medical Screening. 29(1). 12–20. 16 indexed citations

Li, Yuanyuan, et al.. (2021). The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study. JMIR Public Health and Surveillance. 8(3). e33191–e33191. 28 indexed citations

Sun, Xueshan, Xuemei Zhen, Xiaoqian Hu, et al.. (2021). Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis. Annals of Translational Medicine. 9(7). 575–575. 7 indexed citations

Zhen, Xuemei, Cecilia Stålsby Lundborg, Xueshan Sun, et al.. (2021). Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrobial Resistance and Infection Control. 10(1). 5–5. 68 indexed citations

Zhen, Xuemei, Cecilia Stålsby Lundborg, Xueshan Sun, et al.. (2021). Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrobial Resistance and Infection Control. 10(1). 64–64. 3 indexed citations

Li, Yuanyuan, Lingbin Du, Youqing Wang, et al.. (2020). Modeling the Cost-effectiveness of Esophageal Cancer Screening in China. Cost Effectiveness and Resource Allocation. 18(1). 33–33. 5 indexed citations

10.

Sun, Xueshan, et al.. (2020). Effects of expressive writing intervention for women's PTSD, depression, anxiety and stress related to pregnancy: A meta-analysis of randomized controlled trials. Psychiatry Research. 288. 112933–112933. 27 indexed citations

11.

Gu, Shuyan, Xiaoyong Wang, Lizheng Shi, et al.. (2020). Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Quality of Life Research. 29(10). 2695–2704. 18 indexed citations

12.

Zhen, Xuemei, Cecilia Stålsby Lundborg, Meiling Zhang, et al.. (2020). Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China. Scientific Reports. 10(1). 3900–3900. 72 indexed citations

13.

Zhen, Xuemei, Cecilia Stålsby Lundborg, Xueshan Sun, Shuyan Gu, & Hengjin Dong. (2020). Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China. Antibiotics. 9(8). 514–514. 58 indexed citations

14.

Hu, Xiaoqian, Shuyan Gu, Xueshan Sun, et al.. (2019). Cognitive ageing trajectories and mortality of Chinese oldest-old. Archives of Gerontology and Geriatrics. 82. 81–87. 29 indexed citations

15.

Gu, Yuxuan, Jingming Wei, Shuyan Gu, et al.. (2019). Outpatient health-seeking behavior of residents in Zhejiang and Qinghai Province, China. BMC Public Health. 19(1). 967–967. 21 indexed citations

16.

Hu, Xiaoqian, Xueshan Sun, Yuanyuan Li, et al.. (2019). Potential gains in health-adjusted life expectancy from reducing four main non-communicable diseases among Chinese elderly. BMC Geriatrics. 19(1). 16–16. 5 indexed citations

17.

Zhen, Xuemei, Cecilia Stålsby Lundborg, Xueshan Sun, Xiaoqian Hu, & Hengjin Dong. (2019). Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrobial Resistance and Infection Control. 8(1). 137–137. 217 indexed citations

18.

Sun, Xueshan, Xiaoqian Hu, Shuyan Gu, et al.. (2018). Measurement and analysis of equity in health: a case study conducted in Zhejiang Province, China. International Journal for Equity in Health. 17(1). 36–36. 21 indexed citations

19.

Zhen, Xuemei, Xueshan Sun, & Hengjin Dong. (2018). Health Technology Assessment and Its Use in Drug Policies in China. Value in Health Regional Issues. 15. 138–148. 12 indexed citations

20.

Zhen, Xuemei, Xiaoqian Hu, Shuyan Gu, et al.. (2018). A comparative study of catastrophic health expenditure in Zhejiang and Qinghai province, China. BMC Health Services Research. 18(1). 844–844. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact